Journal
KOREAN JOURNAL OF INTERNAL MEDICINE
Volume 36, Issue 4, Pages 767-779Publisher
KOREAN ASSOC INTERNAL MEDICINE
DOI: 10.3904/kjim.2021.176
Keywords
Autosomal dominant polycystic kidney disease; PKD1; PKD2; Disease progression; Tolvaptan
Categories
Funding
- Korea Disease Control and Prevention Agency [2019-ER-7304-00, 2019-ER-7304-01]
Ask authors/readers for more resources
ADPKD is the most common hereditary kidney disease characterized by cyst growth in the kidneys. Genes PKD1 and PKD2 are related to the disease, and predictive tests and clinical factors for disease progression have been established. Ongoing studies in Korean ADPKD patients aim to further understand the genetic and clinical characteristics.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It is characterized by cyst growth in the kidneys, resulting in kidney enlargement and end-stage kidney disease. The polycystic kidney disease 1 (PKD1) and PKD2 have been identified as genes related to ADPKD and their significance in the molecular pathology of the disease has been studied. A disease-modifying drug has been approved; therefore, it has become important to identify patients at a high risk of kidney disease progression. Genetic tests, image analysis methods, and clinical factors for kidney disease progression prediction have been established. This review describes genetic and clinical characteristics, and discusses ongoing studies in Korean ADPKD patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available